Skip to Content
Merck
CN
  • Oncogenic lncRNAs alter epigenetic memory at a fragile chromosomal site in human cancer cells.

Oncogenic lncRNAs alter epigenetic memory at a fragile chromosomal site in human cancer cells.

Science advances (2022-03-03)
Ganesan Arunkumar, Songjoon Baek, David Sturgill, Minh Bui, Yamini Dalal
ABSTRACT

Chromosome instability is a critical event in cancer progression. Histone H3 variant CENP-A plays a fundamental role in defining centromere identity, structure, and function but is innately overexpressed in several types of solid cancers. In the cancer background, excess CENP-A is deposited ectopically on chromosome arms, including 8q24/cMYC locus, by invading transcription-coupled H3.3 chaperone pathways. Up-regulation of lncRNAs in many cancers correlates with poor prognosis and recurrence in patients. We report that transcription of 8q24-derived oncogenic lncRNAs plays an unanticipated role in altering the 8q24 chromatin landscape by H3.3 chaperone-mediated deposition of CENP-A-associated complexes. Furthermore, a transgene cassette carrying specific 8q24-derived lncRNA integrated into a naïve chromosome locus recruits CENP-A to the new location in a cis-acting manner. These data provide a plausible mechanistic link between locus-specific oncogenic lncRNAs, aberrant local chromatin structure, and the generation of new epigenetic memory at a fragile site in human cancer cells.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Anti-DNA-RNA Hybrid Antibody, clone S9.6, clone S9.6, from mouse
Roche
Pepsin, lyophilized (salt-free), ~2500 units/mg protein (At 37 °C with hemoglobin as the substrate. One unit is the enzyme activity which liberates the amount of Tyr producing an increase in the absorbance of 0.001/minute at 280 nm.)